<HashMap><database>biostudies-other</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Liu J</submitter><journal>Frontiers in immunology</journal><pagination>2930</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6300488</full_dataset_link><abstract>? transducin repeat-containing protein (?-TrCP) is a Skp1-Cul1-F-box ubiquitin ligase, which plays important roles in controlling numerous signaling pathways. Notably, ?-TrCP induces ubiquitination and degradation of inhibitor of NF-?B (I?B?), thus triggering activation of NF-?B signaling. Here, we unexpectedly find that ?-TrCP restricts TRAF6-IKK signaling upstream of I?B? induced by lipopolysaccharide (LPS). In LPS-Toll-like receptor 4 (TLR4) pathway, protein kinase D1 (PKD1) is essential for activation of TRAF6-IKK-I?B? signaling including TRAF6 ubiquitination, IKK phosphorylation and subsequent I?B? degradation. We found that LPS promotes binding of ?-TrCP to PKD1, and results in downregulation of PKD1 and recovery of I?B? protein level. Knockdown of ?-TrCP blocks LPS-induced downregulation of PKD1. Supplement of enough PKD1 in cells inhibits recovery of I?B? protein levels during LPS stimulation. Furthermore, we demonstrate that ?-TrCP inhibits LPS-induced TRAF6 ubiquitination and IKK phosphorylation. Taken together, our findings identify ?-TrCP as an important negative regulator for upstream signaling of I?B? in LPS pathway, and therefore renew the understanding of the roles of ?-TrCP in regulating TLRs inflammatory signaling.</abstract><repository>biostudies-other</repository><pmcid>PMC6300488</pmcid><data_source>Europe PMC</data_source><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Zheng H</pubmed_authors><pubmed_authors>Xiao K</pubmed_authors><pubmed_authors>Guo T</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Xu J</pubmed_authors><pubmed_authors>Yuan Y</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>?-TrCP Restricts Lipopolysaccharide (LPS)-Induced Activation of TRAF6-IKK Pathway Upstream of I?B? Signaling.</name><description>? transducin repeat-containing protein (?-TrCP) is a Skp1-Cul1-F-box ubiquitin ligase, which plays important roles in controlling numerous signaling pathways. Notably, ?-TrCP induces ubiquitination and degradation of inhibitor of NF-?B (I?B?), thus triggering activation of NF-?B signaling. Here, we unexpectedly find that ?-TrCP restricts TRAF6-IKK signaling upstream of I?B? induced by lipopolysaccharide (LPS). In LPS-Toll-like receptor 4 (TLR4) pathway, protein kinase D1 (PKD1) is essential for activation of TRAF6-IKK-I?B? signaling including TRAF6 ubiquitination, IKK phosphorylation and subsequent I?B? degradation. We found that LPS promotes binding of ?-TrCP to PKD1, and results in downregulation of PKD1 and recovery of I?B? protein level. Knockdown of ?-TrCP blocks LPS-induced downregulation of PKD1. Supplement of enough PKD1 in cells inhibits recovery of I?B? protein levels during LPS stimulation. Furthermore, we demonstrate that ?-TrCP inhibits LPS-induced TRAF6 ubiquitination and IKK phosphorylation. Taken together, our findings identify ?-TrCP as an important negative regulator for upstream signaling of I?B? in LPS pathway, and therefore renew the understanding of the roles of ?-TrCP in regulating TLRs inflammatory signaling.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 </publication><modification>2019-03-26T22:35:42Z</modification><creation>2019-03-26T22:35:42Z</creation></dates><accession>S-EPMC6300488</accession><cross_references><eva>rs8</eva><pubmed>30619291</pubmed><doi>10.3389/fimmu.2018.02930 </doi></cross_references></HashMap>